John Libbey Eurotext

Epileptic Disorders

The Educational Journal of the

Long-term health-related quality of life in drug-resistant temporal lobe epilepsy after anterior temporal lobectomy Volume 17, issue 2, June 2015

Figures

  • Figure 1
  • Figure 2

Tables

Authors
1 Department of Neurology, Neurological Institute, Taipei Veterans General Hospital
2 Department of Neurology, School of Medicine, National Yang-Ming University
3 Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital
4 Department of Neurosurgery, School of Medicine, National Yang-Ming University, Taipei, Taiwan
* Correspondence: Hsiang-Yu Yu Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, No. 201, Sec. 2 Shih-Pai Rd, Taipei, Taiwan
  • Key words: temporal lobe epilepsy, drug-resistant epilepsy, anterior temporal lobectomy, epilepsy surgery, seizure outcome, quality of life
  • DOI : 10.1684/epd.2015.0744
  • Page(s) : 177-83
  • Published in: 2015

Temporal lobe epilepsy (TLE) is one of the most common drug-resistant epilepsies among adults. Anterior temporal lobectomy (ATL) is an effective treatment for patients suffering from drug-resistant TLE. In addition to the achievement of seizure freedom, an improvement in the health-related quality of life (HRQOL) is another goal of epilepsy surgery. After the development of tools to measure epilepsy-specific HRQOL in the 1990s, HRQOL has become one of the most important outcome assessments for epilepsy [...]